Page last updated: 2024-12-08

3-methylitaconate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

3-methylitaconate: RN refers to (S)-isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6438940
CHEMBL ID4761396
SCHEMBL ID6365923
MeSH IDM0139839

Synonyms (8)

Synonym
3-methylitaconate
AKOS006374421
(2e)-2-ethylidenebutanedioic acid
102714-66-9
SCHEMBL6365923
CHEMBL4761396
DTXSID201347631
(e)-ethylidenesuccinic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1685613Covalent inhibition of wild type N-terminal polyhis-tagged TEV protease cleavage site fused Mycobacterium tuberculosis ICL1 expressed in Escherichia coli BL21 (DE3) using DL-isocitrate as substrate measured after 1 hr by UV-Vis spectrophotometric analysis2021RSC medicinal chemistry, Jan-01, Volume: 12, Issue:1
Itaconate is a covalent inhibitor of the
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]